Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.

Identifieur interne : 004738 ( Main/Exploration ); précédent : 004737; suivant : 004739

Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.

Auteurs : Hiroyuki Kogaki [Japon] ; Yoshiaki Uchida ; Nobuyuki Fujii ; Yoshihiro Kurano ; Kazushige Miyake ; Yasuji Kido ; Hiroaki Kariwa ; Ikuo Takashima ; Hiko Tamashiro ; Ai-Ee Ling ; Masahisa Okada

Source :

RBID : pubmed:16025480

Descripteurs français

English descriptors

Abstract

A novel severe acute respiratory syndrome-associated coronavirus (SARS-CoV) has been discovered. The detection of both antigens and antibodies in SARS-CoV from human specimens with suspected SARS plays an important role in preventing infection. We developed a novel rapid immunochromatographic test (RICT) based on the sandwich format enzyme immunoassay (EIA) with an all-in-one device for detecting the native nucleocapsid antigen (N-Ag) of SARS-CoV using monoclonal antibodies (MoAbs), which we produced by immunizing recombinant N-Ag to mice. RICT is a qualitative assay for respiratory aspirates and serum specimens. With this assay, a positive result can be judged subjectively by the appearance of a blue line on the device 15 min after the sample is applied. RICT with several pairs of MoAbs showed a high sensitivity for the detection of recombinant N-Ag as well as viral N-Ag of SARS-CoV. rSN122 and rSN21-2 were the best MoAbs for immobilized antibody and enzyme labeling, respectively. With regard to analytical sensitivity, RICT detected N-Ag at 31 pg/mL for recombinant N-Ag, and at 1.99 x 10(2) TCID(50)/mL for SARS-CoV. The specificity of RICT was 100% when 150 human sera and 50 nasopharyngeal aspirates (NSPs) were used. RICT based on an EIA using the rSN122/rSN21-2 pair is a sensitive, specific, and reliable rapid assay for detecting N-Ag in SARS-CoV treated with either heat or Triton X-100.

DOI: 10.1002/jcla.20070
PubMed: 16025480


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.</title>
<author>
<name sortKey="Kogaki, Hiroyuki" sort="Kogaki, Hiroyuki" uniqKey="Kogaki H" first="Hiroyuki" last="Kogaki">Hiroyuki Kogaki</name>
<affiliation wicri:level="3">
<nlm:affiliation>Research and Development Division, Fujirebio Inc., Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Research and Development Division, Fujirebio Inc., Tokyo</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Uchida, Yoshiaki" sort="Uchida, Yoshiaki" uniqKey="Uchida Y" first="Yoshiaki" last="Uchida">Yoshiaki Uchida</name>
</author>
<author>
<name sortKey="Fujii, Nobuyuki" sort="Fujii, Nobuyuki" uniqKey="Fujii N" first="Nobuyuki" last="Fujii">Nobuyuki Fujii</name>
</author>
<author>
<name sortKey="Kurano, Yoshihiro" sort="Kurano, Yoshihiro" uniqKey="Kurano Y" first="Yoshihiro" last="Kurano">Yoshihiro Kurano</name>
</author>
<author>
<name sortKey="Miyake, Kazushige" sort="Miyake, Kazushige" uniqKey="Miyake K" first="Kazushige" last="Miyake">Kazushige Miyake</name>
</author>
<author>
<name sortKey="Kido, Yasuji" sort="Kido, Yasuji" uniqKey="Kido Y" first="Yasuji" last="Kido">Yasuji Kido</name>
</author>
<author>
<name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
</author>
<author>
<name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name>
</author>
<author>
<name sortKey="Tamashiro, Hiko" sort="Tamashiro, Hiko" uniqKey="Tamashiro H" first="Hiko" last="Tamashiro">Hiko Tamashiro</name>
</author>
<author>
<name sortKey="Ling, Ai Ee" sort="Ling, Ai Ee" uniqKey="Ling A" first="Ai-Ee" last="Ling">Ai-Ee Ling</name>
</author>
<author>
<name sortKey="Okada, Masahisa" sort="Okada, Masahisa" uniqKey="Okada M" first="Masahisa" last="Okada">Masahisa Okada</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16025480</idno>
<idno type="pmid">16025480</idno>
<idno type="doi">10.1002/jcla.20070</idno>
<idno type="wicri:Area/PubMed/Corpus">002635</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002635</idno>
<idno type="wicri:Area/PubMed/Curation">002635</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002635</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002601</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002601</idno>
<idno type="wicri:Area/Ncbi/Merge">001066</idno>
<idno type="wicri:Area/Ncbi/Curation">001066</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001066</idno>
<idno type="wicri:doubleKey">0887-8013:2005:Kogaki H:novel:rapid:immunochromatographic</idno>
<idno type="wicri:Area/Main/Merge">004A10</idno>
<idno type="wicri:Area/Main/Curation">004738</idno>
<idno type="wicri:Area/Main/Exploration">004738</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.</title>
<author>
<name sortKey="Kogaki, Hiroyuki" sort="Kogaki, Hiroyuki" uniqKey="Kogaki H" first="Hiroyuki" last="Kogaki">Hiroyuki Kogaki</name>
<affiliation wicri:level="3">
<nlm:affiliation>Research and Development Division, Fujirebio Inc., Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Research and Development Division, Fujirebio Inc., Tokyo</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Uchida, Yoshiaki" sort="Uchida, Yoshiaki" uniqKey="Uchida Y" first="Yoshiaki" last="Uchida">Yoshiaki Uchida</name>
</author>
<author>
<name sortKey="Fujii, Nobuyuki" sort="Fujii, Nobuyuki" uniqKey="Fujii N" first="Nobuyuki" last="Fujii">Nobuyuki Fujii</name>
</author>
<author>
<name sortKey="Kurano, Yoshihiro" sort="Kurano, Yoshihiro" uniqKey="Kurano Y" first="Yoshihiro" last="Kurano">Yoshihiro Kurano</name>
</author>
<author>
<name sortKey="Miyake, Kazushige" sort="Miyake, Kazushige" uniqKey="Miyake K" first="Kazushige" last="Miyake">Kazushige Miyake</name>
</author>
<author>
<name sortKey="Kido, Yasuji" sort="Kido, Yasuji" uniqKey="Kido Y" first="Yasuji" last="Kido">Yasuji Kido</name>
</author>
<author>
<name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
</author>
<author>
<name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name>
</author>
<author>
<name sortKey="Tamashiro, Hiko" sort="Tamashiro, Hiko" uniqKey="Tamashiro H" first="Hiko" last="Tamashiro">Hiko Tamashiro</name>
</author>
<author>
<name sortKey="Ling, Ai Ee" sort="Ling, Ai Ee" uniqKey="Ling A" first="Ai-Ee" last="Ling">Ai-Ee Ling</name>
</author>
<author>
<name sortKey="Okada, Masahisa" sort="Okada, Masahisa" uniqKey="Okada M" first="Masahisa" last="Okada">Masahisa Okada</name>
</author>
</analytic>
<series>
<title level="j">Journal of clinical laboratory analysis</title>
<idno type="ISSN">0887-8013</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Monoclonal (immunology)</term>
<term>Chlorocebus aethiops</term>
<term>Chromatography</term>
<term>Coronavirus (immunology)</term>
<term>DNA, Recombinant</term>
<term>Escherichia coli</term>
<term>Immunoenzyme Techniques (instrumentation)</term>
<term>Immunoenzyme Techniques (methods)</term>
<term>Mice</term>
<term>Nucleocapsid (analysis)</term>
<term>Nucleocapsid (immunology)</term>
<term>Reproducibility of Results</term>
<term>Sensitivity and Specificity</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Time Factors</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ADN recombiné</term>
<term>Animaux</term>
<term>Anticorps monoclonaux (immunologie)</term>
<term>Cellules Vero</term>
<term>Chromatographie</term>
<term>Coronavirus (immunologie)</term>
<term>Escherichia coli</term>
<term>Facteurs temps</term>
<term>Nucléocapside (analyse)</term>
<term>Nucléocapside (immunologie)</term>
<term>Reproductibilité des résultats</term>
<term>Sensibilité et spécificité</term>
<term>Souris</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Techniques immunoenzymatiques ()</term>
<term>Techniques immunoenzymatiques (instrumentation)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antibodies, Monoclonal</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Nucléocapside</term>
</keywords>
<keywords scheme="MESH" qualifier="analysis" xml:lang="en">
<term>Nucleocapsid</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Anticorps monoclonaux</term>
<term>Coronavirus</term>
<term>Nucléocapside</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Coronavirus</term>
<term>Nucleocapsid</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en">
<term>Immunoenzyme Techniques</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Immunoenzyme Techniques</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Chromatography</term>
<term>DNA, Recombinant</term>
<term>Escherichia coli</term>
<term>Mice</term>
<term>Reproducibility of Results</term>
<term>Sensitivity and Specificity</term>
<term>Time Factors</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="fr">
<term>ADN recombiné</term>
<term>Animaux</term>
<term>Cellules Vero</term>
<term>Chromatographie</term>
<term>Escherichia coli</term>
<term>Facteurs temps</term>
<term>Reproductibilité des résultats</term>
<term>Sensibilité et spécificité</term>
<term>Souris</term>
<term>Techniques immunoenzymatiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A novel severe acute respiratory syndrome-associated coronavirus (SARS-CoV) has been discovered. The detection of both antigens and antibodies in SARS-CoV from human specimens with suspected SARS plays an important role in preventing infection. We developed a novel rapid immunochromatographic test (RICT) based on the sandwich format enzyme immunoassay (EIA) with an all-in-one device for detecting the native nucleocapsid antigen (N-Ag) of SARS-CoV using monoclonal antibodies (MoAbs), which we produced by immunizing recombinant N-Ag to mice. RICT is a qualitative assay for respiratory aspirates and serum specimens. With this assay, a positive result can be judged subjectively by the appearance of a blue line on the device 15 min after the sample is applied. RICT with several pairs of MoAbs showed a high sensitivity for the detection of recombinant N-Ag as well as viral N-Ag of SARS-CoV. rSN122 and rSN21-2 were the best MoAbs for immobilized antibody and enzyme labeling, respectively. With regard to analytical sensitivity, RICT detected N-Ag at 31 pg/mL for recombinant N-Ag, and at 1.99 x 10(2) TCID(50)/mL for SARS-CoV. The specificity of RICT was 100% when 150 human sera and 50 nasopharyngeal aspirates (NSPs) were used. RICT based on an EIA using the rSN122/rSN21-2 pair is a sensitive, specific, and reliable rapid assay for detecting N-Ag in SARS-CoV treated with either heat or Triton X-100.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
<region>
<li>Région de Kantō</li>
</region>
<settlement>
<li>Tokyo</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Fujii, Nobuyuki" sort="Fujii, Nobuyuki" uniqKey="Fujii N" first="Nobuyuki" last="Fujii">Nobuyuki Fujii</name>
<name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
<name sortKey="Kido, Yasuji" sort="Kido, Yasuji" uniqKey="Kido Y" first="Yasuji" last="Kido">Yasuji Kido</name>
<name sortKey="Kurano, Yoshihiro" sort="Kurano, Yoshihiro" uniqKey="Kurano Y" first="Yoshihiro" last="Kurano">Yoshihiro Kurano</name>
<name sortKey="Ling, Ai Ee" sort="Ling, Ai Ee" uniqKey="Ling A" first="Ai-Ee" last="Ling">Ai-Ee Ling</name>
<name sortKey="Miyake, Kazushige" sort="Miyake, Kazushige" uniqKey="Miyake K" first="Kazushige" last="Miyake">Kazushige Miyake</name>
<name sortKey="Okada, Masahisa" sort="Okada, Masahisa" uniqKey="Okada M" first="Masahisa" last="Okada">Masahisa Okada</name>
<name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name>
<name sortKey="Tamashiro, Hiko" sort="Tamashiro, Hiko" uniqKey="Tamashiro H" first="Hiko" last="Tamashiro">Hiko Tamashiro</name>
<name sortKey="Uchida, Yoshiaki" sort="Uchida, Yoshiaki" uniqKey="Uchida Y" first="Yoshiaki" last="Uchida">Yoshiaki Uchida</name>
</noCountry>
<country name="Japon">
<region name="Région de Kantō">
<name sortKey="Kogaki, Hiroyuki" sort="Kogaki, Hiroyuki" uniqKey="Kogaki H" first="Hiroyuki" last="Kogaki">Hiroyuki Kogaki</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004738 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004738 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16025480
   |texte=   Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16025480" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021